Riskpilot← Back to searchSign inGet full accessMEDIPART ApS
APSActiveCVR 28895399Strandvejen 14, 1.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20051 employeeswww.en-medipart.com.my
Revenue 2025
DKK -65K
-80% vs 2024
EBITDA margin
100.2%
+89% vs 2024
Equity ratio
99.5%
Financial strength
Net profit 2025
DKK 138K
+2864% vs 2024
| Revenue | DKK -65K | -80% |
| EBITDA | DKK -65K | +89% |
| Net profit | DKK 138K | +2864% |
| Total assets | DKK 11,7M | +1% |
| Equity | DKK 11,7M | +1% |
| Employees | 1 | — |
Legal name
MEDIPART ApS
CVR number
28895399
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. juli 2005
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er handel med sygeplejeartikler og dermed beslægtet virksomhed.
Address
Strandvejen 14, 1.
Phone
+4524655885
Email
rikke@medipart.dk
Website
www.en-medipart.com.my
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.041 | 1.467 | 1.048 | 1.612 | 1.255 | 1.077 | 1.252 | 8 | 7.592 | -155 | -706 | -326 | -65 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -412 | -517 | -516 | -543 | -544 | -275 | -0 |
| EBITDA | 1.041 | 1.467 | 1.048 | 1.612 | 1.255 | 1.077 | 840 | -509 | 7.075 | -698 | -1.250 | -600 | -65 |
| Depreciation & amort. | -1 | -4 | -4 | -3 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 1.040 | 1.463 | 1.044 | 1.610 | 1.255 | 1.077 | 840 | -509 | 7.075 | -698 | -1.250 | -600 | -65 |
| Net financials | -9 | 188 | 658 | -757 | 4 | -574 | 254 | 31 | 160 | 1.740 | -273 | 605 | 203 |
| Profit before tax | 1.031 | 1.652 | 1.702 | 852 | 1.259 | 503 | 1.094 | -478 | 7.235 | 1.105 | -1.523 | 5 | 138 |
| Tax | 258 | 405 | 400 | 192 | 277 | 114 | 242 | -105 | 1.592 | 243 | -0 | -0 | -0 |
| Net profit | 774 | 1.247 | 1.302 | 660 | 982 | 389 | 852 | -373 | 5.643 | 862 | -1.523 | 5 | 138 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.188 | 6.033 | 6.039 | 6.275 | 8.945 | 9.606 | 9.518 | 8.891 | 27.242 | 14.122 | 11.589 | 11.573 | 11.709 |
| Equity | 2.945 | 4.191 | 4.368 | 4.678 | 5.660 | 6.049 | 6.901 | 6.528 | 12.171 | 13.033 | 11.510 | 11.515 | 11.653 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.433 | 214 | 0 | 0 | 0 |
| Short-term debt | 1.241 | 1.840 | 1.671 | 1.577 | 3.285 | 3.557 | 2.617 | 2.363 | 13.638 | 875 | 79 | 59 | 56 |
| Total debt | 1.241 | 1.840 | 1.671 | 1.577 | 3.285 | 3.557 | 2.617 | 2.363 | 15.071 | 1.089 | 79 | 59 | 56 |
EBITDA margin
-6465500.0%
This company
15.8%
Market median
-40920986% vs market
20132025
Equity ratio
99.5%
This company
38.2%
Market median
+160% vs market
20132025
Return on equity
1.2%
This company
18.4%
Market median
-93% vs market
20132025
Net profit margin
13810600.0%
This company
8.1%
Market median
+170501135% vs market
20132025
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20132025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20132025
- Annual report 2025Filed via CVR / Virk · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via CVR / Virk · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via CVR / Virk · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via CVR / Virk · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via CVR / Virk · Period 2020-08-01 – 2021-07-31
- Annual report 2020Filed via CVR / Virk · Period 2019-08-01 – 2020-07-31
- Annual report 2019Filed via CVR / Virk · Period 2018-08-01 – 2019-07-31
- Annual report 2018Filed via CVR / Virk · Period 2017-08-01 – 2018-07-31
- Annual report 2017Filed via CVR / Virk · Period 2016-08-01 – 2017-07-31
- Annual report 2016Filed via CVR / Virk · Period 2015-08-01 – 2016-07-31
- Annual report 2015Filed via CVR / Virk · Period 2014-08-01 – 2015-07-31
- Annual report 2014Filed via CVR / Virk · Period 2013-08-01 – 2014-07-31
- Annual report 2013Filed via CVR / Virk · Period 2012-08-01 – 2013-07-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RN Management | Management | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2005 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDIPART ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rikke Nygaard | Management | 0 companies |
| Arini Risma | Board of Directors | 0 companies |